Hematopoietic Development: a Balancing Act

Overview

Journal Curr Opin Genet Dev

Publisher Elsevier

Specialties Biology
Genetics

Date 2001 Sep 5

PMID 11532392

Citations 66

Authors

A B Cantor

S H Orkin

Affiliations

Soon will be listed here.

Abstract

Over the past year, significant new insights have been gained in our understanding of the lineage determination of red blood cells. In particular, evidence has emerged demonstrating that cross-antagonism of lineage-specific transcription factors plays an important role in determining cell phenotype by actively repressing alternate lineage gene programs.

Citing Articles

ID3 promotes erythroid differentiation and is repressed by a TAL1-PRMT6 complex.

Heller V, Wang L, Schneider E, Gerstner M, Bajer L, Decker R J Biol Chem. 2024; 301(2):108119.

PMID: 39716491 PMC: 11847539. DOI: 10.1016/j.jbc.2024.108119.

Data-driven modeling predicts gene regulatory network dynamics during the differentiation of multipotential hematopoietic progenitors.

Handzlik J, Manu PLoS Comput Biol. 2022; 18(1):e1009779.

PMID: 35030198 PMC: 8794271. DOI: 10.1371/journal.pcbi.1009779.

Lineage commitment of hematopoietic stem cells and progenitors: insights from recent single cell and lineage tracing technologies.

Loughran S, Haas S, Wilkinson A, Klein A, Brand M Exp Hematol. 2020; 88:1-6.

PMID: 32653531 PMC: 7747297. DOI: 10.1016/j.exphem.2020.07.002.

The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages.

Repele A, Krueger S, Bhattacharyya T, Tuineau M, Manu PLoS One. 2019; 14(6):e0217580.

PMID: 31181110 PMC: 6557489. DOI: 10.1371/journal.pone.0217580.

High expression of PU.1 is associated with Her-2 and shorter survival in patients with breast cancer.

Lin J, Liu W, Luan T, Yuan L, Jiang W, Cai H Oncol Lett. 2018; 14(6):8220-8226.

PMID: 29344265 PMC: 5755029. DOI: 10.3892/ol.2017.7204.